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Introduction 
An abdominal aortic aneurysm (AAA) is a permanent 
dilatation of the abdominal aorta. An AAA results 
from a multifactorial pathogenesis n which gener- 
alised weakness of the vessel wall; atherosclerosis, 
inflammation and haemodynamic factors may con- 
16 tribute to its occurrence. - Rupture of AAA caused 
1.3% of total mortality in males over 65 years of age in 
England and Wales in 1983. 7 In The Netherlands 1.4% 
of males and 0.5% of females over 55 years of age died 
from ruptured AAA in 1990. 8Worldwide, an increased 
incidence of AAA, partly due to ageing and partly due 
to improved methods to detect aneurysms has been 
observed. 9 From analysis of routine health statistics in 
England and Wales, Fowkes et al. 1° found a 20-fold 
increase in men and an 11-fold increase in women in 
age-standardised AAA mortality over the years 1950 
to 1984. Meanwhile, over the last two decades, stable 
AAA mortality and morbidity rates, in contrast with a 
remarkable decline of other circulatory diseases, were 
observed in Canada. 11 
Approximately 40% of total case fatality occurs 
before hospital admission. 12 After emergency repair of 
ruptured AAA, 40-50% of patients die during or 
within 30 days after operation. 13'14 In contrast with 
high in-hospital mortality of emergency procedures, 
however, elective surgery carries a mortality risk of 
less than 7% .25 
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Several strategies to reduce mortality due to AAA 
rupture have been proposed: (1) primary AAA pre- 
vention, (2) emergency staff and general physicians 
should be familiar with the early warning signs of 
possible rupture, (3) transport and hospital facilities 
should be able to cope with emergency cases, (4) the 
technique of emergency repair should improve, (5) 
AAA rupture should be prevented by introducing 
(large-scale) screening programs and subsequent sur- 
gery for non-ruptured AAA. 
According to recent reports, the latter option has 
been put forward as being the most attractive. Some 
health institutes have started these screening pro- 
grams incorporating epidemiological research. 16-19 
Screening is considered useful when it meets several 
criteria for effectivity, efficiency and efficacy. Effectiv- 
ity means the outcomes of a specific intervention and 
positive (i.e. detection rate or survival rate after 
elective operations) as well as negative side effects. 
Efficiency refers to the ratio of (im)material costs and 
effects (i.e. expenses per life year gained). Efficacy 
refers to the influence of an intervention program on 
reduction of mortality due to AAA rupture of the total 
target population. It should also meet ethical criteria 
with regard to good clinical practice. When the 
usefulness of a screening program is evaluated, death 
due to other diseases, also called competitive or 
concurrent death, should be taken into account. This 
review focuses on the question of whether an AAA 
screening program can be useful to reduce total 
mortality due to AAA rupture, as well as discussing 
gaps in knowledge. 
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Table 1. Criteria for evaluation of the usefulness of a screening 
program by Wilson and Jungner (1968) 20 
1. The disease isan important health problem. 
2. There is a generally accepted treatment of detected patients. 
3. Provisions for diagnosis and treatment are available. 
4. The disease must have a detectable latent stage. 
5. A suitable screening test or research method must be available. 
6. The screening test must be accepted by the target population. 
7. The natural course of the disease must be known. 
8. The policy for treatment ofthe disease must be dear. 
9. The cost-effectiveness of a creening program ust be reasonable. 
10. The treatment ofthe disease should be a continuous process and 
should favour prognosis of patients. 
WHO Criteria for Screening 
Ten criteria to assess the usefulness of a screening 
program were described by Wilson and Jungner 2° 
under the authority of the World Health Organisation 
in 1968 (Table 1). We reviewed the literature to gain 
insights into whether a formal AAA screening pro- 
gram can meet these criteria. Literature published in 
the years 1989 to 1995 was retrieved from Medline 
(CD-ROM) and Current Contents. Mesh-words used 
were aneurysm, risk and screening. Earlier reports 
referred to in 1989-1994 articles were added if neces- 
sary to complement information on the criteria men- 
tioned above. In this article an AAA is defined as a 
permanent localised dilatation with an aortic ante- 
roposterior diameter of a 3.0cm and (or) > 1.5 times 
times the anteroposterior diameter of the proximal 
aorta. 2~ As the effect of variable definitions of AAA 
was extensively described by Moher et al., 22 attention 
is paid to any potential bias introduced by using other 
standards. 
Criterion 1. AAA is an important health problem 
AAA morbidity and mortality 
Mean prevalence of AAA in the elderly population 
aged 65-80 years is 4% 19 and varies between 5-9% in  
elderly males. 16'18'23 In addition, prevalence of AAA 
increases with age. 17 The contributions of AAA as a 
pr imary cause of total annual mortality was about 
1.4% in males and 0.5% in females over 55 years of age 
in The Netherlands in 1990. 8It has been estimated that 
AAA is responsible for approximately 1300 deaths in 
The Netherlands in 19908 and for more than 10000 
deaths in the U.K. each year. 24 Melton et al. 25 and 
Eickhoff 26 suggested a possible decreasing trend in 
age-standardised AAA mortality in the future due to 
cohort effects and effective emergency surgery, 
whereas Norman et al. 27 claimed the opposite giving 
the argument of competitive death. Only 40-60% of 
patients with ruptured AAA reach hospital alive and 
about 40-50% of this group survive emergency 
repair. 12"28"29 Various risk factors such as age, cardiac 
and pulmonary status were suggested as having a 
negative influence on survival. The gender of patients 
did not influence mortality of emergency surgery. 3° 
Economic implications 
The workload of aortic surgery in an English district 
was reported to have increased 4-fold over 10 years 
due to risen incidence of aneurysm rupture. 28 Mean 
length of hospital stay of patients with emergency 
repair markedly increased from 14 to 17 days, whereas 
hospital stay of patients with repair of non-ruptured 
AAA decreased from 22 to 17 days over the last 10 
years in The Netherlands. 31 In the U.S. mean post- 
operative stay for emergency repair was calculated to 
be 34 days and for elective repair 14 days. 32 
High-risk target population for screening 
A better efficiency may be achieved when screening 
programs target high risk groups. Such a group can be 
selected on the basis of four categories of possible risk 
factors for AAA development: 
Biological factors. As AAA is mainly an ageing process, 
the elderly are an accepted risk population. 33 Morris et 
a l J  recorded a small abdominal aortic aneurysm in 
2.0%, 6.3% and 7.8% of men 50-64 years, 65-79 years 
and over 80 years of age, respectively. Aneurysms 
> 4.5 cm were found in another 0.3%, 2.5% and 4.1% of 
these age bands. In males, AAA is reported to be three 
to four times more prevalent than in females. Higher 
AAA prevalence in whites as compared to non-whites 
were demonstrated by Lilienfeld et al. 34 A genetic 
component has also been proposed. In case-referent 
studies, prevalence of 17-29% among brothers and 
4-7% among sisters of AAA patients were found. 3s-39 
Genetic factors seem to play a role in the pathogenesis 
of AAA, but the mode of inheritance and mechanisms 
of gene-environment interaction remain unclear. 4° 
Although many authors uggest a genetic omponent, 
interpretation of additive risks is often biased. Recall 
bias is a common problem in retrospective studies, 
whereas selection bias distorts the associations in 
studies in which the patient/relative ratio is more than 
one. Selection bias may also be introduced by includ- 
ing participants uspected of degenerative disease. 
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These may lead to an overestimation of individual 
risks. In addition, many studies lack a proper referent 
population threatening eneralisation of results to the 
general elderly population. 
Mechanical factors. An independent higher risk for all 
types of fatal aneurysms among hypertensive males, 
as opposed to males with normal blood pressure, was 
observed in a long-term follow-up among 18403 male 
civil servants. 41 Although this was confirmed by 
O'Kelly and Heather, 42 it remains doubtful whether 
hypertension causes the development of AAA (risk 
factor) or is only associated with AAA (indicator). 
Others like Collin et aI. 16 and Scott et al. 19 did not find 
any correlation between blood pressure and preva- 
lence of AAA. It was pointed out that most studies 
assess this relationship among the elderly, while 
younger hypertensive persons may develop AAA 
earlier. 43 More evidence for hypertension as a risk 
factor especially in younger age groups has been 
44 introduced by Grimshaw et al. In this studN hyper- 
tensives aged 60-64 years experienced an AAA almost 
three times more often an AAA as opposed to age- 
matched controls. Overall to distinguish the effect of 
blood pressure on AAA independent from other 
factors (such as level of cholesterol HDL, LDL and 
structure of the vascular wall or life-style) remains 
difficult and has not been well reported yet. 
Life-style factors. The influence of smoking habits on 
development and course of AAA is uncertain. Ciga- 
rette smoking plays a role in the development and 
progression of aortic atherosclerosis. 45 Recently, some 
correlation between previous moking behaviour and 
growth rate of AAA has been demonstrated. 46 In the 
White-Hall study, 41 smoking habits were found to be 
an important risk factor for all types of fatal aneu- 
rysms in multivariate analyses. During 18 years of 
follow-up the investigators howed a surprisingly 
variable dose-effect response. Relative risks of aneu- 
rysms in ex-smokers (relative risk of 6.5), current 
smokers of manufactured cigarettes (relative risk 6.7), 
and smokers of handrolled cigarettes (relative risk 25) 
were calculated compared to life-long non-smokers. 
These relative risks may, however, differ when death 
due to ruptured AAA is being considered specifically. 
O'Kelly and Heather 42 reported some lower, but 
substantial elevated risks of AAA > 4.0 cm in smokers 
compared to non-smokers. Also, younger patients 
(mean age 51 years) with aortic aneurysms were more 
often smokers than older patients (mean age 70 
years) .47 Dietary factors may be underestimated in the 
development of AAA. 48 At present, none of these 
dietary components have been considered in multi- 
variate risk analyses. 
Presence of disease. A two-fold increase in the presence 
of cardiac disease in men aged 65-75 years with non- 
ruptured AAA compared to men without AAA of the 
same age category was reported. 49 This finding 
strengthened earlier evidence of higher AAA preva- 
lence among patients with occlusive peripheral vas- 
cular disease than in the general elderly popula- 
tion. 5°-5a AAA may therefore be considered a marker 
of extensive atherosclerosis and a symptom of degen- 
eration of the cardiovascular system.5*Therefore, the 
use of extended screening of patients with small AAA 
for other cardiovascular diseases has been suggested 
by Geroulakos and Nicolaides. 24 
Although the above mentioned factors may be 
associated with an increased AAA prevalence, these 
factors do not necessarily induce rupture of AAA. Risk 
of ru ture mainly de ends on size and growth 
rate. 5~518 Faggioli et al.59Puggested that morphological 
characteristics ould be predictive for rupture. 
At present, the following riskgroups for AAA have 
been defined: (1) males over 65 years of age, (2) 
hypertensives, (3) claudicants and (4) brothers of AAA 
patients. It must be emphasized that attributable risks 
for non-ruptured AAA in selected high-risk groups 
may not exceed 20-25% compared to the elderly 
population (2-6%). Restricting screening according to 
the aforementioned criteria in order to construct a 
well-defined high-risk group may leave many poten- 
tial non-ruptured AAA undetected in the population. 
Furthermore, targeting high-risk patients may yield 
patients with severe cardiovascular or other ageing 
diseases, whose surgical procedure related risk is 
higher. 6° 
Criterion 2. Generally accepted treatment of 
detected patients 
The standard procedure to prevent rupture of AAA 
consists of a major operation, in which by the 
transabdominal or retroperitoneal route a straight or 
bifurcated graft is interpositioned in the aorta. 61 In- 
hospital mortality depends on the local experience 
and referral patterns, and reaches 2--5% for asympto- 
matic AAA repair and 13-27% for symptomatic 
unruptured AAA repair. 62 In the U.S., mortality rates 
of repair for both symptomatic and asymptomatic 
AAA decreased from 14 to 6% in the last decade, 
whereas mortality rates for ruptured AAA averaged at 
50% and did not improve. 63 
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Other serious postoperative complications are less 
well reported. In 730 electively and emergency oper- 
ated patients 18% cardiac, 8% pulmonary and 6% 
cerebrovascular short-term complications were 
reported. 64 Retrospectively, Lachapelle et al. 6s found 
25% of non-cardiac morbidity after elective AAA 
repair in 146 patients. Among high-risk patients who 
underwent elective surgery even one in three 
appeared to suffer from a serious postoperative 
complication, the most common of which was a 
cardiac event. 66 Unreported graft infection, aortoen- 
teric fistula and graft occlusion take longer to develop 
and should be considered when long-term survival 
after surgery is investigated. 
Recently, a less invasive and perhaps more effective 
endovascular p othesis has been proposed for selected 
cases. 67-71 An intraluminal stent-graft device is 
inserted via a remote access, e.g. the femoral artery, 
and passed up inside the aortic aneurysm under 
fluoroscopic ontrol. However, this technique requires 
a specific morphology of the aneurysm and is only 
suitable for a selected group of patients. Studies on the 
efficiency and safety of this operative technique are 
required before it can be applied on a large scale. 
At the moment non-invasive interventions to pre- 
vent the development of aneurysms are not available. 
However, studies on the aetiology of aneurysms may 
yield possibilities for prevention by means of prophy- 
lactic action with medical drugs in future. 72"73 
Criterion 3. Provisions for diagnosis and 
intervention must be available 
Abdominal Ultrasonography (US) has improved accu- 
racy over physical examination, particularly in 
uncomplicated aortic aneurysms. 74Computed tomog- 
raphy (CT) has also been mentioned as an imaging 
technique for the detection of unruptured AAA. For 
screening purposes US seems to be most appropriate 
(see criterion 5) as it is widely available. The equip- 
ment can be used by vascular nurses or radiographers 
(ultrasonographers) in hospitals, or with portable 
equipment, even at the patient's own home. 
A remarkable difference in rates of success of 
surgery for non-ruptured as well as for ruptured AAA 
among surgeons and hospitals is observed. 14"48"75-78 
Experience with this type of surgery determines 
whether a surgical department should perform elec- 
tive surgery. 
Criterion 4. AAA must have a detectable latent 
stage 
In view of the poor prognosis after rupture, screening 
has been proposed. Almost all asymptomatic aneu- 
rysms of the abdominal aorta can be detected by 
means of US. 79 
Though the presence of asymptomatic AAA can be 
detected accuratel)~ the screening interval is still a 
subject of debate. The optimal frequency and time of 
ultrasound examinations depend on the age of the 
patient, growth rate of the aneurysm and criteria for 
elective surgery. Recentlj~ a single scan for male 
persons at the age of 65 years and follow-up only for 
those detected with an AAA sized > 2.6 cm has been 
suggested, g° This finding is in accordance with col- 
lective previous evidence from other studies. 16'19'42 In 
contrast, Khoo et al. 81 recommended a second scan at 
the age of 70 years to pick up another 3.7% with AAA 
of later onset. A screening interval of 2 years appeared 
to be suitable for aneurysms less than 4.0 cm. g2 Apart 
from screening elderly males at the age of 65 years, it 
has also been advised to add some specific groups 
such as young patients with hypertension to the total 
formal screening cohort. 44 
Criterion 5. A suitable screening test or research 
method must be available 
The diagnosis of AAA can be made in various ways 
including physical examination, plain abdominal 
radiography, MR-imaging, angiography, CT and 
Ultrasonography. US is the most appropriate for 
screening purposes. It is relatively cheap, sensitivity 
and specificity of US are estimated to be high ( _ 95%). 
Portable US apparatus is available. In addition, it is 
claimed to be cost-effective and reproducible within a 
83 detection range less than 2.2 mm. Exceptions to this 
rule must be made for obese patients and patients 
with excessive bowel gas or periaortic disease. Intra- 
observer differences may be present, 84 but were 
negligible under standardised conditions, g5 While US 
provides sufficient information for screening pur- 
poses, the planning of an elective operation will 
require more detailed anatomical information. Spiral 
CT and CT-angiography can provide essential 
images. 86,87 
Criterion 6. The screening test must be accepted 
by the target population 
US is painless, non-invasive and does not involve 
Eur J Vasc Endovasc Surg Vol 11, April 1996 
274 E. Hak et al. 
physical inconvenience for the patient. No study has 
been carried out so far to assess possible effects of 
screening on psychological quality of life or psycho- 
logical well-being. It is conceivable that AAA screen- 
ing may cause depression, decreased positive attitude 
or anxiety. 88"89 
The attendance rates of screening programs may be 
interpreted as a marker for acceptance. The majority of 
AAA screening programs attain attendance rates 
reported to be between 40 and 80%. 16"17'90-92 Age 
appeared to influence attendance rate negatively. 
Significantly lower attendance rates among older as 
opposed to younger persons were recorded. ~7'81 
Screening programs targeting families of patients may 
yield a lower impact than general screening, as many 
relatives have been reported to live outside the 
screening area. B6 The efficacy of screening programs is 
at stake if many persons cannot be reached or refuse 
participation. Also lack of personal interest, little 
understanding and poor health are assumed to be fatal 
for the success of elective repair. 9B 
Criterion 8. The surgical strategy for 
non-ruptured AAA must be clear 
In designing an intervention strategy for elective 
surgery, knowledge of many aspects of the natural 
course (criterion 7) and prophylactive intervention of 
AAA (criterion 2) is required. In a report of a 
subcommittee of the Joint Council of the Society for 
Vascular Surgery and the North American Chapter of 
the International Society for Cardiovascular Surger~ 6~' 
a clear policy for surgery of both ruptured and non- 
ruptured AAA is outlined in which effectiveness of
intervention is assumed to be optimal. Three major 
issues require attention in the decision for elective 
repair: size and (or) growth rate of the aneurysm, 
underlying disease and expected survival rate. The 
report suggests that all patients with aneurysms sized 
more than 4.0 cm should be operated on. However 
this criterion may need revision after the results of the 
small aneurysm trials are known. Many reports 
already suggest a more conservative attitude towards 
these small aneurysms especially for ~atients with 
concomitant cardiorespiratory disease. 24'55'99'1°3-105 
Criterion 7. The natural course of AAA must be 
known 
Although the first report on elective resection of AAA 
dates from 195294 and first epidemiological studies on 
the natural course of AAA started in the late seven- 
ties, 95 aetiological and prognostic factors for onset, 
expansion rate and rupture of AAA are still unknown. 
Lacking prospective data on natural course, many 
investigators focused on describing factors associated 
with risk of rupture. Size of the aortic diameter and 
growth rate of aneurysms appeared to be significantly 
correlated with rupture (criterion 1). Moreover, size 
and growth rate seem to be interdependent, which 
suggests exponential risks with increasing size. 96 
Despite abundant information on such risk factors, 
prediction of rupture for an individual remains impre- 
cise. Although some authors demonstrated rupture 
rates exceeding 25% in large sized AAA (~ 5.0 cm), 
another 50-75% did not rupture at all after 3-5 
years .55'97 Incidence of rupture of small sized aneu- 
rysms seems to be less than 8% after 5 years of follow- 
up. 98'99 Scott et al. ~°° reported a considerably lower 
rupture rate among AAA patients with a maximum 
diameter of less than 6.0 cm. Incidence of rupture of 
small aneurysms is under investigation in the U.K. 
(Small aneurysm Trial, Charing Cross Hospital) 1°1 and 
the U.S. (ADAM study). 1°2 The first results will be 
presented by the end of the decade. 
Criterion 9. Cost-effectiveness of an AAA 
screening program must be reasonable 
A cost-effective analysis views all results in economic 
terms, including years of life gained. 1°6 The criterion 
for cost-effectiveness i  the ratio of expenditures of a 
screening program and elective surgery to the net 
effectiveness in terms of enhanced life expectancy. The 
cost-effectiveness of a well-defined AAA screening 
program can only reliably be assessed in a controlled 
trial in which persons are either randomly assigned to 
a screening program or treated only when otherwise 
found. No studies have included these cost-effective 
analyses o far. 
Bengtsson et aI. 1°7 and Frame et al. ~°8 used mathe- 
matical modelling to predict cost-effectiveness 
expressed as costs per life year gained. Sensitivity 
analyses revealed important clues on which factors of 
AAA screening influence cost-effectiveness. In these 
analyses, assumptions were made concerning the 
prevalence or annual incidence of AAA, size at 
operation, mortality rates, incidence of rupture, inci- 
dence of case finding, validity of screening test, annual 
all-cause death and costs of screening as well as 
elective surgery and follow-up visits. Although these 
analyses yield comparable rough approximations of 
these variables, results indicate variable economic 
costs per life year gained. In the first study men of the 
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ageband 60 to 80 years were screened once by physical 
examination, confirmed by US whereas in the second 
all males over 60 years of age only underwent US. 
Calculations revealed $28 741 and $7583 per life year 
saved. Therefore, as both authors suggest, studies 
based on critical issues such as detection rate of 
unruptured AAA by (incidental) case finding, proba- 
bility of rupture of small aneurysms, proportion of 
patients with post-operative complications, creening 
intervals and long-term survival rates of electively 
operated patients are essential. 
Criterion 10. Prophylactic treatment of 
non-ruptured AAA should be a continuous 
process and should improve the prognosis of 
patients 
Prophylactic treatment can impose a considerable 
burden on health institutes and the capacity of surgery 
departments. Therefore, well-organised financial and 
logistic facilities are important requirements for con- 
tinuation of such a preventive health campaign. 
Long-term patient based studies on prognosis of 
electively operated patients are rare. In-hospital mor- 
tality, defined as death during admission for elective 
surgery or within 30 days after operation, may 
underestimate long-term mortality in these patients. 
Long-term survival rate after 5 years in electively 
operated AAA patients appeared to be similar to age- 
and sex-matched controls from the general population 
as reported by Rohrer et al. ~°9 This finding, however, is 
in direct conflict with Johnston's 11° observation. He 
demonstrated a considerable decrease in survival after 
5 years in these patients as opposed to age- and sex- 
matched controls of the Canadian population. Long- 
term survival after elective surgery was approx- 
imately 60% after 6 years and appeared to be about 
18% lower than the survival rate of matched controls. 
In many of Johnston's patients comorbidity was 
present. It should be realised that elective repair in 
many of these cases may lead to competitive 
death, m 
Discussion 
The technical and logistical feasibility of screening for 
AAA does not appear to form a major obstacle. 
However, controversy exists concerning effectivitN 
efficiency and efficacN the role of ethics and com- 
petitive death. Firstly, there is much debate about the 
effectivity (effectiveness) by introducing a screening 
program. Although many authors emphasise the fact 
that at least 5-8%of elderly males are affected by 
mostly small abdominal aortic aneurysms, it is doubt- 
ful whether these aneurysms will rupture during life. 
In view of the observation that mean age of patients 
with ruptured aneurysms i  about 70-75 years and life 
expectancy of males is about the same, many of them 
will die of other causes. This is confirmed by much 
lower age-standardised AAA mortality rates. There- 
fore, some authors suggested enhanced efficiency 
when targeting high-risk groups. Hypertensives seem 
to be more than twice as much affected by AAA, but 
the role of hypertension as a risk factor for early 
rupture has not been clarified until now. Brothers of 
patients have been reported to have an attributable 
risk of 20% as opposed to elderly males, but bias in 
these studies cannot be excluded. Finally, patients 
with underlying disease are most at risk, but in these 
patients the outcome of elective surgery is much 
worse. 
Health profit due to elective repair of unruptured 
AAA depends on postoperative mortality as well as 
morbidity. In experienced hands, hospital mortality of 
asymptomatic unruptured AAA is less than 5%. 
However, postoperative morbidity rates of 20-30% of 
severe short-term complications were reported. Long- 
term postoperative complications such as graft rejec- 
tion, infection or leaking may also occur, but these are 
not well reported. 
A clear intervention policy favours effectivity. An 
optimal strategy yields an individual examination, 
rather than outlining general rules for all patients. 
Surgeons should carefully weigh the individual 
chance of rupture of AAA and of dying due to elective 
repair. The lack of essential information about the 
natural course of AAA has led to a situation in which 
even small aneurysms (~ 5.0 cm) are being operated 
upon. RecentlN researchers from the U.K. and U.S. 
have decided to assess the effectivity of such opera- 
tions. The results of these important trials are awaited 
with considerable interest. 
SecondlN assessment of the efficiency of an AAA 
screening program is at a premature stage. Results of 
simulation studies indicate high economic osts per 
life year gained. However, it must be observed that 
these computerised decision programmes just approx- 
imate reality. Thirdly, low attendance rates may 
threaten efficacy. Reported rates vary enormouslN 
mainly due to difference in recruitment and target 
population. Overall, screening once at younger age 
(about 60-65 years of age) may prevent low rates ai~d 
enhance fficacy. Ethical views of screening for AAA 
are a fourth controversy. In this, two aspects may be 
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l ooked upon:  (1) are surgeons able to dec ide careful ly 
and  convinc ing ly  whether  a pat ient  wi l l  actual ly  
benef it  f rom elective repair? and  (2) does screening 
y ie ld  any k ind  of psycho log ica l  stress for ind iv idua ls  
or society? The first aspect  is c losely assoc iated w i th  a 
clear in tervent ion  policy. The second is under  inves-  
t igat ion and  wi l l  need more  attent ion,  because at 
present  society asks for many dif ferent heal th  promo-  
t ion act ions wh ich  make deep inroads  into social life. 
Compet i t ive  morta l i ty  as a final controversy  may p lay  
an impor tant  role in p revent ing  diseases at o ld  age. 
Comorb id i ty  is not on ly  of impor tance  for the out-  
come of t reatment:  pat ients  w i th  other  ser ious heal th  
compla ints  who surv ive appear  to have an increased 
r isk of dy ing  of other  heal th  re lated causes in a short  
t ime. This means  a decreased overal l  heal th  prof it  of 
such a screening program.  
A l though many authors  focus on screening pro-  
grams,  more  attent ion shou ld  be pa id  to other solu- 
t ions for AAA as a hea l th  prob lem.  112-115 A var ie ty  of 
act ions to reduce the occurrence of AAA may inc lude 
d ietary  modi f icat ions,  aggress ive t reatment  of hyper -  
tens ion and a chang ing  att i tude of the publ ic  towards  
smoking.  Both recogni t ion of ear ly  warn ing  signs of 
rupture  and  opt ima l  care for emergency  cases may be 
at ta ined by  educat ion  programs target ing genera l  
pract i t ioners  and  other  heal th  phys ic ians.  Also,  some 
authors  propose  improv ing  case- f ind ing by  general  
pract i t ioners,  rad iographers  and  other heal th  special-  
ists. Morta l i ty  due  to emergency  operat ions  for rup-  
ture remained  constant  over  the last two decades.  
Studies on factors wh ich  cause low rates of survival ,  
such as d iagnost ic  or logist ical  prob lems,  are needed 
most  urgently.  
In conclusion,  the usefulness of in t roduc ing  a 
formal  screening program shou ld  be s tud ied  more  
extensively. A long i tud ina l  contro l led trial in wh ich  
the surp lus  va lue of a screening program compared  to 
case- f ind ing as part  of normal  cl inical pract ice is 
p robab ly  required.  
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